A rem-ARCC-able Update - CADTH.ca · PDF fileA rem-ARCC-able Update Dr. Jeffrey Hoch1,4,5...
-
Upload
phungkhanh -
Category
Documents
-
view
223 -
download
2
Transcript of A rem-ARCC-able Update - CADTH.ca · PDF fileA rem-ARCC-able Update Dr. Jeffrey Hoch1,4,5...
A d v a n c i n g H e a l t h E c o n o m i c s , S e r v i c e s , P o l i c y a n d E t h i c s
A rem-ARCC-able Update
Dr. Jeffrey Hoch1,4,5
Sarah Benn1,4
Dr. Stuart Peacock1,2
Kimberly van der Hoek1,2
1. Canadian Centre for Applied Research in Cancer Control (ARCC), 2. British Columbia Cancer Agency, 3. University of British Columbia, 4. Cancer Care Ontario, 5. University of Toronto
*
Canadian Centre for Applied
Research in Cancer Control (ARCC)
ARCC Network
Program Leads
Investigators Associates
Network Members
Health Technology Assessment
Murray Krahn & Jeffrey Hoch
Health Systems, Services & Policy
Craig Earle & Mary McBride
Societal Values Public Engagement
Jennifer Gibson & Stuart Peacock
Patients & Families
Christopher Longo & Arminee Kazanjian
Knowledge Translation Research
Melissa Brouwers
Research Areas and Program Leads
Canadian Centre for Applied
Research in Cancer Control (ARCC)
ARCC Network
Program Leads
Investigators Associates
Network Members
• Lisa Barbera
• George Browman
• Mark Elwood
• Jennifer Gibson
• David Hodgson
• Nicole Mitttman
• Carol Sawka
• Beth Kapusta
• Morris Barer
• Tony Culyer
• Neil Hagen
• Murray Krahn
• Steve Morgan
• Terry Sullivan
• Scott Berry
• Matt Dobrow
• Konrad Fassbender
• Bart Harvey
• Louise Lemieux -Charles
• Susan O’Reilly
• Simon Sutcliffe
• Melissa Brouwers
• Richard Doll
• David Henry
• Mary McBride
• Jolie Ringash
• Ross Upshur
• Bob Evans
ARCC Investigators
Canadian Centre for Applied
Research in Cancer Control (ARCC)
ARCC Network
Program Leads
Investigators Associates
Network Members
• Nick Bansback
• Shawn Budgen
• Natasha Leighl
• Kimberly McGrail
• Erin Strumpf
• Greg Zaric
• Yvonne Bombard
• Roger Chafe
• Eva Grunfeld
• Geoffrey Liu
• Craig Mitton
• Rosie Thein
• Michael Burgess
• Marc Brisson
• Craig Earle
• Jennifer Jones
• Christopher Longo
• Chris Skedgel
• Frances Wong
• Stirling Bryan
• Lise Fillion
• Arminee Kazanjian
• Deborah Marshall
• Hsien Seow
• Dominika Wranik
ARCC Associates
Canadian Centre for Applied
Research in Cancer Control (ARCC)
ARCC Network
Program Leads
Investigators Associates
Network Members
• Academics
• Researchers
• Students
• Clinicians
• Policy makers
• Decision makers
ARCC Network Members
ARCC enables and enhances research
ARCC enables research
– By making it possible
How we do it?
– Seed grant competitions
– Strategic investments
ARCC enhances research
– By engaging different researchers to work collaboratively
How we do it?
– “match making”
– ARCC Network
– Capacity building
www.cc-arcc.com/network/presentations
*
Members Benefit From ARCC
Database ARCC Get
Connected
ARCC
Newsletter- landmARCC
Canada wide resource
Conferences, workshops &
seminars
Grants
A Variety of Resources for HTA
ARCC
Connect with
decision makers
Expand your research network
Funding Opportunities
Mentorship
A d v a n c i n g H e a l t h E c o n o m i c s , S e r v i c e s , Po l i c y a n d E t h i c s
How would you like to get involved?
Contact us For more information about ARCC please see our website at www.cc-arcc.ca or contact us at [email protected]
BC Cancer Research Centre (BCCA) Cancer Care Ontario (CCO)
675 West 10th Ave 620 University Ave
Vancouver, BC V5Z 1L3 Toronto, ON M5G 2L7
604-675-8000 x7054 416-971-9800 x1 3738
Phase-specific and lifetime costs of cancer in British Columbia and Ontario Principal Investigator: Krahn M Co-Investigators: Shabbir A, Barer M , Farahati F, Hoch J , Laporte A, Machado M, Naglie G, Paszat L, Peacock S , Tomlinson
The cost-effectiveness of intensity-modulated radiation therapy (IMRT) Principal Investigator: Hoch J.
Early detection of lung cancer – a pan-Canadian study Principal Investigator: Lam S Co-Investigators: Tsao MS, Yee J, McWilliams A, Mayo J, Peacock S , Finley R, Evans K, Sin D, Wan T, Burrows P, Liu G, Tremblay A, MacEachern P, Evans B, Tammemagi M, Goffin J, Roberts H, Shepherd F, Sophrati K, Thenganatt J, Leighl N, Puksa S, Stewart L, Goss G, Nicholas G, Laberge F, Gingras M, Johnston M, Seely J, Manos D, Amjadi K, Martel S
Cancer Pharmacoeconomics Evaluation and Research Program Principal Investigator: Hoch J.
The cost-effectiveness of cancer drugs funded by the New Drug Funding Program: providing evidence of the value of medicines in delivering expected outcomes
Principal Investigator: Hoch J , Krahn M
Co-Investigators: Bell C, Gavura S, Grootendorst P, Hodgson D , Mamdani M, Peacock S , Sawka C , Sullivan T , Trudeau M, Woodward G
Genomic, Imaging and Modelling Approaches to Advance Population-Based Colorectal Cancer Screening
Principal Investigator: Tai I
Co-Investigators: Coldman A, Macaulay C, Peacock S , Elwood M , Zeng H
(A) – ARCC funded research
* – Other funding
HTA Research
A 2-year follow-up study of the health effects of androgen deprivation therapy in men with non-metastatic prostate cancer
Principal Investigator: Alibhai, S
Co-investigators: Fleshner N, Krahn M, Naglie G
Androgen deprivation therapy in prostate cancer patients: patterns of care, lifetime costs, and cost effectiveness of ADT treatment
Principal Investigator: Krahn M
Co-investigators: Alibhai S, Laporte A, Naglie G, Tomlinson G, Trachtenberg J, Warde P.
A Randomized Controlled Evaluation of HPV Testing for Cervical Cancer Screening
Principal Investigator: Coldman A
Co-Investigators: Davies P, Martin R, Matisic J, van Niekerk D, Ogilvie G, Ehlen T, Stuart G, Franco E, Peacock S , Krajden M
From Disease Gene Mapping to Clinical Practice – A Provincial Program in Clinical Genomics
Principal Investigator: Siminovitch K.
Co-Investigators: Heathcote J, Ozcelik H, Laurent B.
Post-doctoral fellow: Djalalov, Sandjar
Optical Techniques and Oral Pre-cancer Management
Principal Investigator: Rosin MP
Co-Investigators: Garner D, Guillaud M, Hislop TG, Lane P, Le ND, Macaulay C, Peacock S , Poh C, Williams PM, Zhang
Cost-effectiveness of erlotinib for 2nd and 3rd line use in metastatic lung cancer
Principal Investigator: Peacock S
Co-Investigators: van der Hoek K , Melosky B, Taylor S, Johnston K, Cromwell I
HTA Research Continued
Valuing cancer interventions: is there a cancer premium?
Principal Investigator: Peacock, S
Co-Investigators: Gibson, J, Teckle P
Comparisons in costs of end-of-life care in lung cancer patients in Ontario and the United States
Principal Investigators: Krahn M
Co-Investigators: Barbera L, Hoch J, Warren J, Yabroff R
HTA Research Continued